Search research articles
Contact Us
Filters
Showing results (71-80 of 114) with videos related to
Page
of 12
Sort By:
Cell Reports
|
October 6, 2021
B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination
Prerna Arora, Anzhalika Sidarovich, Nadine Krüger, et al.
Cell Host & Microbe
|
May 19, 2022
SARS-CoV-2 Omicron sublineages show comparable cell entry but differential neutralization by therapeutic antibodies
Prerna Arora, Lu Zhang, Nadine Krüger, et al.
The Lancet. Infectious Diseases
|
December 4, 2025
Integrase versus protease inhibitor therapy in advanced HIV disease (LAPTOP): a multicountry, randomised, open-label, non-inferiority trial
Georg M N Behrens, Lambert Assoumou, Geoffroy Liegeon, et al.
Virology
|
September 9, 2025
Host cell entry efficiency and neutralization sensitivity of the SARS-CoV-2 MC.10.1 variant
Lu Zhang, Amy Kempf, Inga Nehlmeier, et al.
Vaccines
|
November 26, 2024
Comparative Analysis of Host Cell Entry Efficiency and Neutralization Sensitivity of Emerging SARS-CoV-2 Lineages KP.2, KP.2.3, KP.3, and LB.1
Nianzhen Chen, Katharina Emma Decker, Sebastian R Schulz, et al.
Cell
|
January 13, 2022
The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic
Markus Hoffmann, Nadine Krüger, Sebastian Schulz, et al.
International Journal of Molecular Sciences
|
November 26, 2022
The SARS-CoV-2 Delta-Omicron Recombinant Lineage (XD) Exhibits Immune-Escape Properties Similar to the Omicron (BA.1) Variant
Prerna Arora, Lu Zhang, Cheila Rocha, et al.
Vaccines
|
May 25, 2024
Virological Traits of the SARS-CoV-2 BA.2.87.1 Lineage
Lu Zhang, Alexandra Dopfer-Jablonka, Inga Nehlmeier, et al.
Nature Communications
|
January 18, 2025
Reverse mutational scanning of SARS-CoV-2 spike BA.2.86 identifies epitopes contributing to immune escape from polyclonal sera
Najat Bdeir, Tatjana Lüddecke, Henrike Maaß, et al.
Cell Reports
|
July 16, 2021
SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination
Markus Hoffmann, Heike Hofmann-Winkler, Nadine Krüger, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 114) with videos related to
Sort By:
Page
of 12
Cell Reports
|
October 6, 2021
B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination
Prerna Arora, Anzhalika Sidarovich, Nadine Krüger, et al.
Cell Host & Microbe
|
May 19, 2022
SARS-CoV-2 Omicron sublineages show comparable cell entry but differential neutralization by therapeutic antibodies
Prerna Arora, Lu Zhang, Nadine Krüger, et al.
The Lancet. Infectious Diseases
|
December 4, 2025
Integrase versus protease inhibitor therapy in advanced HIV disease (LAPTOP): a multicountry, randomised, open-label, non-inferiority trial
Georg M N Behrens, Lambert Assoumou, Geoffroy Liegeon, et al.
Virology
|
September 9, 2025
Host cell entry efficiency and neutralization sensitivity of the SARS-CoV-2 MC.10.1 variant
Lu Zhang, Amy Kempf, Inga Nehlmeier, et al.
Vaccines
|
November 26, 2024
Comparative Analysis of Host Cell Entry Efficiency and Neutralization Sensitivity of Emerging SARS-CoV-2 Lineages KP.2, KP.2.3, KP.3, and LB.1
Nianzhen Chen, Katharina Emma Decker, Sebastian R Schulz, et al.
Cell
|
January 13, 2022
The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic
Markus Hoffmann, Nadine Krüger, Sebastian Schulz, et al.
International Journal of Molecular Sciences
|
November 26, 2022
The SARS-CoV-2 Delta-Omicron Recombinant Lineage (XD) Exhibits Immune-Escape Properties Similar to the Omicron (BA.1) Variant
Prerna Arora, Lu Zhang, Cheila Rocha, et al.
Vaccines
|
May 25, 2024
Virological Traits of the SARS-CoV-2 BA.2.87.1 Lineage
Lu Zhang, Alexandra Dopfer-Jablonka, Inga Nehlmeier, et al.
Nature Communications
|
January 18, 2025
Reverse mutational scanning of SARS-CoV-2 spike BA.2.86 identifies epitopes contributing to immune escape from polyclonal sera
Najat Bdeir, Tatjana Lüddecke, Henrike Maaß, et al.
Cell Reports
|
July 16, 2021
SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination
Markus Hoffmann, Heike Hofmann-Winkler, Nadine Krüger, et al.
Page
of 12